Reprogramming– tag –
-
Membrane-Fusogenic Nanoparticles Revolutionize Gene & Cell Therapy: Enhancing NK Cell Anti-Tumor Activity with Precision Delivery
ACS Publications International Overview Membrane-fusogenic nanoparticles are emerging as a versatile platform for precise and efficient therapeutic delivery in gene and cell therapy. These nanoparticles can engineer adoptive cells for su... -
REPROCELL Offers High-Quality Clinical-Grade iPSC Services with Proprietary StemRNA™ 3rd Gen Technology, Including Reprogramming, Differentiation, and Gene Editing
REPROCELL Japan Overview REPROCELL provides comprehensive, high-quality iPSC reprogramming, differentiation, and gene editing services utilizing its proprietary StemRNA™ 3rd Gen Reprogramming technology. These services encompass efficien... -
In Vivo CAR-T Cell Therapy Demonstrates Clinical Proof-of-Concept with AI Acceleration: Enabling Direct In-Body Immune Cell Gene Editing Towards ‘Off-the-Shelf Biologics’
OncoDaily International Overview While autologous CAR-T cell therapy yields durable remissions in B-cell malignancies, its delivery model faces persistent challenges. In vivo CAR-T emerges as a radically different approach, delivering CA... -
Liv Hospital Advances iPSC Reprogramming, Sets Sights on Scalable Production for Regenerative Medicine
Liv Hospital Turkey Overview Liv Hospital's latest research details critical optimizations in induced pluripotent stem cell (iPSC) reprogramming, emphasizing advanced gene delivery systems and optimal vector selection for efficient and s... -
MDPI Paper Analyzes Direct Cellular Reprogramming Advances and Challenges: Functional Transformation of Fibrotic Tissues vs. Safety and Efficiency Bottlenecks
MDPI Switzerland Overview A scholarly article in MDPI reviews advances in direct cellular reprogramming for regenerative medicine, highlighting its potential to transform fibrotic tissues into functional parenchyma. However, it criticall...
1